These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23067161)

  • 21. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease.
    Wesson DE; Buysse JM; Bushinsky DA
    J Am Soc Nephrol; 2020 Mar; 31(3):469-482. PubMed ID: 31988269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alkaline Diet: a Novel Nutritional Strategy in Chronic Kidney Disease?
    Yari Z; Mirmiran P
    Iran J Kidney Dis; 2018 Jul; 12(4):204-208. PubMed ID: 30087214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
    Wesson DE; Simoni J
    Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences and therapy of the metabolic acidosis of chronic kidney disease.
    Kraut JA; Madias NE
    Pediatr Nephrol; 2011 Jan; 26(1):19-28. PubMed ID: 20526632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic acidosis and progression of chronic kidney disease: incidence, pathogenesis, and therapeutic options.
    Ortega LM; Arora S
    Nefrologia; 2012; 32(6):724-30. PubMed ID: 23169354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of chronic metabolic acidosis in patients with chronic kidney disease.
    Kopple JD; Kalantar-Zadeh K; Mehrotra R
    Kidney Int Suppl; 2005 Jun; (95):S21-7. PubMed ID: 15882309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid and mineral balances and bone in familial proximal renal tubular acidosis.
    Lemann J; Adams ND; Wilz DR; Brenes LG
    Kidney Int; 2000 Sep; 58(3):1267-77. PubMed ID: 10972690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?
    Kovesdy CP
    Nephrol Dial Transplant; 2012 Aug; 27(8):3056-62. PubMed ID: 22851628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease.
    Siener R
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29677110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
    Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
    Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of oral alkali supplementation on progression of chronic kidney disease.
    Gaggl M; Sliber C; Sunder-Plassmann G
    Curr Hypertens Rev; 2014; 10(2):112-20. PubMed ID: 25549843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients.
    Ismail N
    Semin Nephrol; 1997 Jul; 17(4):270-84. PubMed ID: 9241713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic effects of metabolic acidosis on renal function and structure.
    Tammaro G; Zacchia M; Zona E; Zacchia E; Capasso G
    J Nephrol; 2018 Aug; 31(4):551-559. PubMed ID: 29700802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on inflammation in chronic kidney disease.
    Akchurin OM; Kaskel F
    Blood Purif; 2015; 39(1-3):84-92. PubMed ID: 25662331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening and management of metabolic acidosis in patients with chronic kidney disease].
    Georges B; Huart J; Krzesinski JM; Jouret F
    Rev Med Suisse; 2018 Aug; 14(615):1455-1458. PubMed ID: 30136461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors.
    Phisitkul S; Hacker C; Simoni J; Tran RM; Wesson DE
    Kidney Int; 2008 Jan; 73(2):192-9. PubMed ID: 17978813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic acidosis components in advanced chronic kidney disease: association with serum albumin and parathyroid hormone.
    Vasconcelos DP; Bayas de Queiroz RE; Ponte Costa TM; Rocha Guerreiro MQ; Oliveira Leitão MA; Corrêa LC; Libório AB
    J Ren Nutr; 2015 May; 25(3):271-5. PubMed ID: 25443692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of renal osteodystrophy in peritoneal dialysis.
    Weinreich T
    Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.